The court’s decision could have broader implications for lawsuits seeking to hold companies liable for international human rights abuses.
Category: Liability for Products
-
Supreme Court Appears Skeptical of Falun Gong Lawsuit Against Cisco
The New York Times – Business: -
Supreme Court Appears Divided Over Roundup Weedkiller Case
The New York Times – Business:The case could help determine the future of thousands of lawsuits against the maker of a popular herbicide over claims that it causes cancer.
-
Republicans Seek Protections for Oil Giants Against Climate Lawsuits
The New York Times – Business:Utah passed a law to insulate oil companies against efforts to make them pay for their role in global warming. A nationwide version is in the works.
-
Supreme Court Sides With Internet Provider in Copyright Fight Over Pirated Music
The New York Times – Business:Leading music labels sued Cox Communications for failing to terminate accounts of subscribers flagged for distributing copyrighted music.
-
Boston Scientific Knew of Pacemaker Battery Problems for Years
The New York Times – Business:Boston Scientific announced multiple recalls but has said its battery issues were limited. One internal test in 2025 found batteries with an “extremely high failure rate.”
-
A Study Is Retracted, Renewing Concerns About the Weedkiller Roundup
Problems with a 25-year-old landmark paper on the safety of Roundup’s active ingredient, glyphosate, have led to calls for the E.P.A. to reassess the widely used chemical.
-
The Gamble Behind a Takeover of Kenvue, Maker of Tylenol
Potentially huge legal issues are hovering over Kenvue. But Kimberly-Clark, which agreed to buy it for $40 billion, appears to think they’re manageable.
-
Jury Awards $50 Million to California Man Burned by Starbucks Tea
Michael Garcia, 30, underwent skin grafts on his genitals after a hot tea spilled on him in a Starbucks drive-through in 2020, his lawyers said.
-
Five Ways R.F.K. Jr. Could Undermine Lifesaving Childhood Vaccines
If he is confirmed as H.H.S. secretary, the longtime vaccine critic would be in a position to change the government’s immunization recommendations and delay the development of new vaccines.
-
Zantac’s Developer Settles Lawsuits Claiming Cancer Link
GSK, which developed and sold versions of the now-discontinued blockbuster heartburn drug, agreed to pay up to $2.2 billion.
-
Sacklers Threatened with Lawsuits from States and Creditors for Purdue Pharma
Legal maneuverings followed a Supreme Court ruling last month that denied the Sackler family immunity from liability over its role in the opioid crisis.